| Author | Wist, Martin | dc.contributor.author |
| Date of accession | 2021-04-06T13:55:45Z | dc.date.accessioned |
| Available in OPARU since | 2021-04-06T13:55:45Z | dc.date.available |
| Date of first publication | 2020 | dc.date.issued |
| Language | en | dc.language.iso |
| Publisher | Universität Ulm | dc.publisher |
| Dewey Decimal Group | DDC 570 / Life sciences | dc.subject.ddc |
| Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
| MeSH | Leukemia, Lymphocytic, Chronic, B-Cell | dc.subject.mesh |
| MeSH | Type C phospholipases | dc.subject.mesh |
| MeSH | Receptors, Antigen, B-Cell | dc.subject.mesh |
| MeSH | Phosphoproteins | dc.subject.mesh |
| MeSH | Protein kinase inhibitors; Therapeutic use | dc.subject.mesh |
| Title | Molecular consequences of mutations in the gene encoding phospholipase C-gamma-2 causing immune dysregulation syndromes and resistance to ibrutinib in chronic lymphocytic leukemia | dc.title |
| Resource type | Dissertation | dc.type |
| Date of acceptance | 2020-12-14 | dcterms.dateAccepted |
| Referee | Gierschick, Peter | dc.contributor.referee |
| Referee | Johnsson, Nils | dc.contributor.referee |
| PPN | 1753198178 | dc.identifier.ppn |
| GND | Chronisch-lymphatische Leukämie | dc.subject.gnd |
| GND | Phospholipase C | dc.subject.gnd |
| Faculty | Fakultät für Naturwissenschaften | uulm.affiliationGeneral |
| Institution | UKU. Institut für Pharmakologie und Toxikologie | uulm.affiliationSpecific |
| Institution | Institut für Molekulare Genetik und Zellbiologie | uulm.affiliationSpecific |
| Grantor of degree | Fakultät für Naturwissenschaften | uulm.thesisGrantor |
| DCMI Type | Text | uulm.typeDCMI |
| Category | Publikationsnachweise | uulm.category |
| University Bibliography | ja | uulm.unibibliographie |
